¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"stress diabetes"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • stress protein
    ½ºÆ®·¹½º´Ü¹éÁú
  • stress quadric
    ÀÀ·ÂÀÌÂ÷°î¸é
  • stress reaction
    ½ºÆ®·¹½º¹ÝÀÀ
  • stress test
    ºÎÇϰ˻ç, Àڱذ˻ç
  • stress ulcer
    ½ºÆ®·¹½º±Ë¾ç
  • stress urinary incontinence
    º¹¾Ð¿ä½Ç±Ý, º¹¾Ð¿ÀÁÜ»õ±â, ½ºÆ®·¹½º¿ä½Ç±Ý
  • stress-reduction technique
    ½ºÆ®·¹½º°¨¼Ò±â¹ý
  • stress-related disorder
    ½ºÆ®·¹½º°ü·ÃÀå¾Ö
  • surgical stress
    ¼ö¼ú½ºÆ®·¹½º
  • shearing stress
    Àü´ÜÀÀ·Â, Àü´Ü½ºÆ®·¹½º
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • stress incontinence
    º¹¾Ð¿ä½Ç±Ý, º¹¾ÐÂñ²ûÁõ
  • stress management
    ½ºÆ®·¹½º°ü¸®
  • stress protein
    ½ºÆ®·¹½º´Ü¹éÁú
  • stress quadric
    ÀÀ·ÂÀÌÂ÷°î¸é
  • radial acceleration stress
    ¿ø½É°¡¼Óµµ½ºÆ®·¹½º
  • residual stress
    ÀÜ·ù½ºÆ®·¹½º
  • stress reaction
    ½ºÆ®·¹½º¹ÝÀÀ
  • stress
    ½ºÆ®·¹½º, ºÎÇÏ
  • shearing stress
    ¾ù°¥¸²Èû, Ãþ¹Ð¸®±âº¯Çü·Â
  • stress test
    ºÎÇϰ˻ç, Àڱذ˻ç
  • stress vulnerability
    ½ºÆ®·¹½ºÃë¾à¼º
  • stress-reduction technique
    ½ºÆ®·¹½º°¨¼Ò±â¹ý
  • surgical stress
    ¼ö¼ú½ºÆ®·¹½º
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • stress proteins
    ½ºÆ®·¹½º´Ü¹éÁú(¡­Ó±ÛÜòõ)
  • stress quadric
    ÀÀ·ÂÀÌÂ÷°î¸é(ëëæ³ì£ó­ ÍØØü).
  • stress reaction
    ½ºÆ®·¹½º¹ÝÀÀ(~Úãëë).
  • stress reaction, acute situational
    ±Þ¼º»óȲ¼º(ÐáàõßÒüÏàõ) ½ºÆ®·¹½º¹ÝÀÀ.
  • stress response
    ½ºÆ®·¹½º¼º ¹ÝÀÀ(¡­àõ Úãëë)
  • stress strain diagram
    ÀÀ·ÂÀǷ»óŵµ(ëëæ³ èàæ³ßÒ÷¾Óñ).
  • stress test
    ºÎÇϰ˻ç(ݶùÃËþÞÛ).
  • stress test
    ºÎÇϰ˻ç
  • stress testing
    ºÎÇϽÃÇè(ݶùÃãËúÐ).
  • stress ulcer
    ½ºÆ®·¹½ºÃÏ?¡­Ï÷åË).
  • stress ulcer
    ½ºÆ®·¹½º ±Ë¾ç(¡­Ï÷åË)
  • stress vulnerability
    ½ºÆ®·¹½º Ãë¾à¼º(öªå°àõ).
  • stress-reduction techniques
    ½ºÆ®·¹½º °¨¼Ò±â¹ý(~Êõá´ÐüÛö).
  • stress-related disorders
    ½ºÆ®·¹½º °ü·ÃÀå¾Ö(º´).
  • surgical stress
    ¼ö¼ú½ºÆ®·¹½º.
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
DSE dobutamine stress echoradiography; Doctor of Sanitary Engineering
DUSOCS Duke social support and stress scale
EDCS end-diastolic chamber stiffness; end-diastolic circumferential stress
EST electric shock threshold; electroshock therapy; endometrial sinus tumor; endoscopic sphincterectomy;...
ESWS end-systolic wall stress
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
GDM Gestacional Diabetes Mellitus
GD Gestational Diabetes
GDM Gestational Diabetes
IDDM I-insulin-dependent diabetes mellitus
IDDM Insulin Dependent Diabetes
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
galactose diabetes <biochemistry> A rare genetic (autosomal recessive) disorder characterised by the inability a defect in the enzyme (galactose 1 phosphate uridyl transferase) that converts galactose 1 phosphate into glucose 1 phosphate is absent.
Excess galactose 1 phosphate accumulates in the blood and a variety of problems result.
Inheritance: autosomal recessive.
Origin: Gr. Haima = blood
(27 Sep 1997)
pancreatic diabetes Diabetes mellitus demonstrably dependent upon a pancreatic lesion, diabetes following removal of the pancreas in an animal.
(05 Mar 2000)
vasopressin-resistant diabetes Diabetes insipidus due to inability of the kidney tubules to respond to antidiuretic hormone; X-linked inheritance, with full expression in males and partial defect in heterozygous females.
Synonym: vasopressin-resistant diabetes.
(05 Mar 2000)
gestational diabetes A glucose intolerance which occurs in pregnancy, usually noticed between the 24th and 28th weeks of pregnancy. In most cases the blood glucose level returns to normal after delivery. Although the symptoms of this form of diabetes are mild and nonserious for the mother, elevated blood glucose in the mother has been associated with an increased risk of foetal and newborn death. Risk factors for gestational diabetes include maternal age over 25, family history of diabetes, obesity, birth weight over 9 lb in a previous delivery or a history for congenital birth defect or death, in a previous newborn.
(27 Sep 1997)
maturity-onset diabetes Non-insulin-dependent diabetes mellitus.
(05 Mar 2000)
maturity onset diabetes of youth A relatively mild, non-insulin requiring form of diabetes mellitus beginning at a younger age than usual.
(05 Mar 2000)
renal diabetes The recurring or persistent excretion of glucose in the urine, in association with blood glucose levels that are in the normal range; results from the failure of proximal renal tubules to reabsorb glucose at a normal rate from the glomerular filtrate (low renal threshold); defect in the glucose carrier in the nephron.
Synonym: diabetes innocens, normoglycaemic glycosuria, renal diabetes.
(05 Mar 2000)
chemical diabetes A mild form of diabetes mellitus in which the patient displays no overt symptoms, but displays certain abnormal responses to diagnostic procedures, such as an elevated fasting blood glucose concentration or reduced glucose tolerance.
Synonym: chemical diabetes.
(05 Mar 2000)
metahypophysial diabetes Diabetes mellitus caused by large quantities of endogenous or exogenous pituitary growth hormone, term used to designate the irreversible phase of diabetes mellitus in acromegaly.
(05 Mar 2000)
growth-onset diabetes A chronic condition in which the pancreas makes little or no insulin because the beta cells have been destroyed. The body is then not able to use the glucose (blood sugar) for energy. IDDM usually comes on abruptly, although the damage to the beta cells may begin much earlier. The signs of IDDM are a great thirst, hunger, a need to urinate often, and loss of weight. To treat the disease, the person must inject insulin, follow a diet plan, exercise daily, and test blood glucose several times a day. IDDM usually occurs in children and adults who are under age 30. This type of diabetes used to be known as juvenile diabetes, juvenile-onset diabetes, and ketosis-prone diabetes.
(09 Oct 1997)
phlorizin diabetes The presence of sugar in the urine after the experimental administration of phlorizin, which results in a lower renal threshold for glucose reabsorption of glucose.
Synonym: phlorizin diabetes.
(05 Mar 2000)
phosphate diabetes Excessive secretion of phosphate in the urine due to a defect in tubular reabsorption; usually part of a more generalised abnormality, such as Fanconi syndrome.
(05 Mar 2000)
piqure diabetes Experimental diabetes produced in animals by puncture of the floor of the fourth ventricle of the brain.
Synonym: piqure diabetes.
(05 Mar 2000)
Mosler's diabetes Inosituria with excretion of large quantities of water.
(05 Mar 2000)
pregnancy diabetes See: subclinical diabetes.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
ÅëÇÕ°Ë»ö ¿Ï·á